Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Open House Pharmaceutical Dact Treaties Brinzolamid And Brimonidin, Atc S01ec24 2025-09-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Felbamat, Atc N03ax10 For The Period 01.08.2025 - 31.07.2027 2025-09-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Ponesimod, Atc L04ae04 For The Period 01.08.2025 - 31.07.2027 2025-09-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Melatonin (exclusively 1mg And 5mg), Atc N05ch01 For The Period 01.08.2025 - 31.2012027 2025-09-15
Germany Open House Pharmaceutical Department Treaties Erythropoietin Zeta, Atc B03ax01 2025-09-15
Germany Open House Pharmaceutical Department Treaties Tolvaptan, Except Medicines With Uniform Effects, Atc G04bx21 2025-09-15
Germany Open House Pharmaceutical Department Treaties Erythropoietin Zeta, Atc B03ax01 2025-09-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Tralokinumab, Atc D11ah07 For The Period 01.08.2025 - 31.07.2027 2025-09-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Melatonin (exclusively 1mg And 5mg), Atc N05ch01 For The Period 01.08.2025 - 31.2012027 2025-09-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Nomegestrol + Estradiol, Atc G03aa14 For The Period 01.08.25 - 31.07.27 (plus Extension Option 1x12 Month) 2025-09-15
Whats app